Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
galiximab
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
galiximab
Unique ID
C437823
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C437823
Entry Term(s)
IDEC-114
P-16C10
anti-B7-1 mAb
primatized anti-B7 antibody
Pharm Action
Anti-Inflammatory Agents
Antineoplastic Agents
Registry Numbers
S9OX9692ZB
Related Numbers
357613-77-5
Heading Mapped to
*Antibodies, Monoclonal
Frequency
21
Note
for the treatment of lymphoma, autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis
Source
Curr Opin Investig Drugs 2001 May;2(5):635-8
Date of Entry
2001/10/24
Revision Date
2019/10/31
Expand All
Collapse All
galiximab
Preferred
Concept UI
M0403023
Registry Numbers
S9OX9692ZB
Related Numbers
357613-77-5
Terms
galiximab
Preferred Term
Term UI
T612078
Date
10/05/2004
LexicalTag
NON
ThesaurusID
IDEC-114
Narrower
Concept UI
M0403024
Terms
IDEC-114
Preferred Term
Term UI
T467694
Date
10/24/2001
LexicalTag
LAB
ThesaurusID
NLM (2001)
P-16C10
Narrower
Concept UI
M0403025
Terms
P-16C10
Preferred Term
Term UI
T467695
Date
10/24/2001
LexicalTag
LAB
ThesaurusID
NLM (2001)
anti-B7-1 mAb
Narrower
Concept UI
M000654657
Terms
anti-B7-1 mAb
Preferred Term
Term UI
T467693
Date
10/24/2001
LexicalTag
NON
ThesaurusID
NLM (2001)
primatized anti-B7 antibody
Term UI
T467692
Date
10/24/2001
LexicalTag
NON
ThesaurusID
NLM (2001)
page delivered in 0.005s